my.chemeurope.com
With an accout for my.chemeurope.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
06-28-2010: Saltigo GmbH has passed an audit by the U.S. Food and Drug Administration (FDA) with a “No Findings” rating. Saltigo’s Managing Director Wolfgang Schmitz is delighted that the official auditors did not have any objections: “The FDA audit is an internationally accredited seal of quality and recognizes all the work we have put in. This shows not just U.S. customers but also pharmaceutical companies throughout the world that with us the production of active ingredients is in safe and reliable hands.”
The audit focused on testing production and quality assurance processes for an active ingredient that a Saltigo customer is looking to supply in the United States in the near future. It involved the auditors inspecting Saltigo’s production and quality assurance systems in Leverkusen over five days. As part of this pre-approval inspection, the FDA assesses whether a medical product can be manufactured at the company’s production facilities using technology that is recognized in the United States as state-of-the-art and in compliance with applicable CGMP rules (Current Good Manufacturing Practice).
The auditors also inspect quality assurance systems and all the facilities used, from water treatment plants and cleanrooms to filling plants and process control technology. Immediately afterwards, the FDA announces the results of its audit, ranging from “No Findings” and “Form 483” (negative findings observed) to the “Warning Letter” (critical negative findings).
“An FDA audit is a particularly tough test,” says Dr. Carsten Hesse, responsible for quality assurance in the Pharma business line at Saltigo. “This excellent “No Findings” result is a testament to our high standards. But meeting CGMP requirements with ease and flexibility and doing so in all scales of synthesis is all in a day’s work for us.”
Contact / Request information
Request further information free of charge:
Watchlist
This is where you can add this news to your personal favourites
Former Lufthansa building renamed “LANXESS Tower”
Specialty chemicals company LANXESS will be able to welcome employees, customers and guests to the “LANXESS Tower” from the middle of next year. This is the new name chosen for the company's future headquarters on Deutzer Freiheit in Cologne. In summer 2011, LANXESS asked its employees to h ... more
LANXESS expands Jhagadia site to serve booming Indian market
LANXESS is continuing to expand its Indian production site in Jhagadia, Gujarat state. The specialty chemicals group is underlining its commitment to the subcontinent by inaugurating three new plants this month to serve the growing India market. LANXESS has invested over EUR 70 million and ... more
LANXESS to build plant in Lipezk in Russia
The German specialty chemicals group LANXESS is focusing on the megatrend of mobility on the Russian market too. At its new site in Lipezk, LANXESS subsidiary Rhein Chemie will produce rubber additives and release agents for the Russian and CIS markets, especially for the automotive and tir ... more
LANXESS is Germany’s largest listed specialty chemicals group and operates in all important markets of the world. Its core business comprises the development, manufacture and sale of high-tech plastics, high-performance rubber, specialty chemicals and intermediates. In addition, it helps it ... more
LANXESS is listed as the fourth largest German Chemistry Corporation in the Frankfurt Stock Exchange. With our extensive portfolio we are active in all the markets of the world. Our product pallet ranges from base, specialty and fine chemicals to plastics and rubbers. In addition, we sup ... more
LANXESS Sybron Chemicals Inc., provides world-class ion exchange resins to meet the needs of numerous applications. The global strength of Lewatit ion exchange resins in industrial water and chemical processing markets is joined with the solid position Ionac ion exchange resins enjoy in the ... more
New head of Saltigo’s Agro & Fine Chemicals business line
Effective February 1, 2012, Joerg Schneider, Managing Director of LANXESS Elastômeros do Brasil S.A., will assume management of the Agro & Fine Chemicals business line of Saltigo GmbH. The 49-year-old will succeed Dr. Uwe Brunk, who is leaving the company at his own request. Schneider began ... more
Saltigo focuses on palladium-catalyzed cross-coupling reactions
Palladium-catalyzed cross-coupling reactions have become an important cornerstone of modern organic synthesis chemistry. They have made a wide variety of active pharmaceutical ingredients, natural substances and other complex organic molecules economically accessible. The award of this year ... more
Joint separation: Cooperation will extend service offerings of LANXESS subsidiary
Saltigo GmbH, the specialist in custom synthesis based in Langenfeld, Germany, and Reuter Chemische Apparatebau KG (RCA) of Freiburg, Germany, concluded a cooperation agreement on October 1. The companies will jointly develop processes for the synthesis of active pharmaceutical ingredients ... more
Saltidin®- proven active ingredient for insect repellents
Saltidin® is a proven active ingredient for insect repellents. It protects against deadly diseases from mosquitoes, flies and ticks more
Saltigo GmbH is a globally operating custom manufacturing specialist, providing services in the pharmaceutical, agro- & specialty chemical industry. Saltigo combines the flexibility of a midsize company with the financial stability and coverage of a global player. With a comprehensive set ... more
About CHEMIE.DE
CHEMIE.DE Information Service GmbH runs specialist scientific internet portals. The secret to our success? We are familiar with what we publish.
Advertising at CHEMIE.DE
Our advertising formats support you in getting your message across to a clearly defined target audience.
© 1997-2011 CHEMIE.DE Information Service GmbH, All rights reserved
